发布求助
文献互助 智能选刊 最新文献

Biotechnology healthcare最新文献

筛选
英文 中文
Antibody-Drug Conjugates: Where the Action Is: ADCs - The New Frontier. 抗体-药物偶联物:作用所在:adc -新前沿。
Biotechnology healthcare Pub Date : 2012-01-01
Bob Carlson
{"title":"Antibody-Drug Conjugates: Where the Action Is: ADCs - The New Frontier.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Next generation antibody-drug conjugates, like T-DM1, are meant to kill the cancer - not the patient.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 4","pages":"28-31"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524741/pdf/bh0904028.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31146713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Seeing daylight. 看到日光。
Biotechnology healthcare Pub Date : 2012-01-01
Katherine T Adams
{"title":"Seeing daylight.","authors":"Katherine T Adams","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 3","pages":"1"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474452/pdf/bh0903001.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30995267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
iSPOT-D Trial Has Potential To Personalize Antidepressant Treatment. iSPOT-D试验有可能个体化抗抑郁治疗。
Biotechnology healthcare Pub Date : 2012-01-01
Bob Carlson
{"title":"iSPOT-D Trial Has Potential To Personalize Antidepressant Treatment.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 3","pages":"31-2"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474448/pdf/bh0903031.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30995278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Employers target rising specialty drug costs. 雇主们的目标是不断上涨的特种药品成本。
Biotechnology healthcare Pub Date : 2012-01-01
Katherine T Adams
{"title":"Employers target rising specialty drug costs.","authors":"Katherine T Adams","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 3","pages":"33"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474450/pdf/bh0903033.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30995279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can we afford the war on cancer? 我们能负担得起对抗癌症的战争吗?
Biotechnology healthcare Pub Date : 2012-01-01
Ed Silverman
{"title":"Can we afford the war on cancer?","authors":"Ed Silverman","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Immunotherapy vaccines could extend survival in a handful of cancers. But personalizing treatment, payers argue, is not sustainable. Where should the line be drawn?</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 4","pages":"13-6"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524749/pdf/bh0904013.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31146712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biologics clinical trials, research, and FDA actions. 生物制剂临床试验、研究和FDA行动。
Biotechnology healthcare Pub Date : 2012-01-01
Michael D Dalzell
{"title":"Biologics clinical trials, research, and FDA actions.","authors":"Michael D Dalzell","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 2","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411234/pdf/bh0902004.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30821322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Medical Process Patents Declared Invalid: The Prometheus case restricts patent protection and the growth of personalized medicine. 医疗过程专利宣布无效:普罗米修斯案限制了专利保护和个性化医疗的发展。
Biotechnology healthcare Pub Date : 2012-01-01
Joanna T Brougher
{"title":"Medical Process Patents Declared Invalid: The Prometheus case restricts patent protection and the growth of personalized medicine.","authors":"Joanna T Brougher","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 2","pages":"26-7"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3411232/pdf/bh0902026.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30821329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety. 创新与竞争:生物仿制药会成功吗?当前位置建立FDA批准生物仿制药的途径是复杂且充满危险的。是的，创新和市场竞争正处于危急关头。但疗效和患者安全也是如此。
Biotechnology healthcare Pub Date : 2012-01-01
Erwin A Blackstone, Joseph P Fuhr
{"title":"Innovation and Competition: Will Biosimilars Succeed?: The creation of an FDA approval pathway for biosimilars is complex and fraught with hazard. Yes, innovation and market competition are at stake. But so are efficacy and patient safety.","authors":"Erwin A Blackstone,&nbsp;Joseph P Fuhr","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Biosimilars are here, but there's no clear pathway yet for their approval. Difficult realities about their effect on drug prices, innovation, and competition need to be faced.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 1","pages":"24-7"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351893/pdf/bh0901024.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30627063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Saving dollars, preventing disappointment. 省钱，避免失望。
Biotechnology healthcare Pub Date : 2012-01-01
Bob Carlson
{"title":"Saving dollars, preventing disappointment.","authors":"Bob Carlson","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 1","pages":"28-9"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351890/pdf/bh0901028.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30627064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To Heal the Body, Get Into the Patient's Head: Motivational Interviewing: To improve adherence. 治疗身体，进入病人的头脑:动机性访谈:提高依从性。
Biotechnology healthcare Pub Date : 2012-01-01
Jack McCain
{"title":"To Heal the Body, Get Into the Patient's Head: Motivational Interviewing: To improve adherence.","authors":"Jack McCain","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>For patients, poor adherence to biologics can increase risks of morbidity and mortality. For payers, it means money down the drain. Here's a tool that proponents say can help change patient behavior.</p>","PeriodicalId":89534,"journal":{"name":"Biotechnology healthcare","volume":"9 4","pages":"10-2"},"PeriodicalIF":0.0,"publicationDate":"2012-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3524743/pdf/bh0904010.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"31146711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信